全文获取类型
收费全文 | 5866篇 |
免费 | 328篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 303篇 |
儿科学 | 68篇 |
妇产科学 | 65篇 |
基础医学 | 929篇 |
口腔科学 | 116篇 |
临床医学 | 325篇 |
内科学 | 1378篇 |
皮肤病学 | 70篇 |
神经病学 | 531篇 |
特种医学 | 185篇 |
外科学 | 767篇 |
综合类 | 60篇 |
预防医学 | 208篇 |
眼科学 | 52篇 |
药学 | 585篇 |
中国医学 | 17篇 |
肿瘤学 | 571篇 |
出版年
2023年 | 27篇 |
2022年 | 69篇 |
2021年 | 114篇 |
2020年 | 66篇 |
2019年 | 82篇 |
2018年 | 95篇 |
2017年 | 79篇 |
2016年 | 97篇 |
2015年 | 80篇 |
2014年 | 136篇 |
2013年 | 157篇 |
2012年 | 238篇 |
2011年 | 321篇 |
2010年 | 149篇 |
2009年 | 134篇 |
2008年 | 248篇 |
2007年 | 269篇 |
2006年 | 242篇 |
2005年 | 290篇 |
2004年 | 304篇 |
2003年 | 256篇 |
2002年 | 235篇 |
2001年 | 242篇 |
2000年 | 239篇 |
1999年 | 206篇 |
1998年 | 71篇 |
1997年 | 73篇 |
1996年 | 73篇 |
1995年 | 53篇 |
1994年 | 62篇 |
1993年 | 52篇 |
1992年 | 158篇 |
1991年 | 146篇 |
1990年 | 140篇 |
1989年 | 120篇 |
1988年 | 118篇 |
1987年 | 114篇 |
1986年 | 113篇 |
1985年 | 96篇 |
1984年 | 68篇 |
1983年 | 54篇 |
1982年 | 33篇 |
1981年 | 24篇 |
1980年 | 22篇 |
1979年 | 39篇 |
1978年 | 26篇 |
1977年 | 27篇 |
1974年 | 23篇 |
1973年 | 19篇 |
1971年 | 20篇 |
排序方式: 共有6230条查询结果,搜索用时 15 毫秒
91.
H Nakashima J Balzarini R Pauwels D Schols J Desmyter E De Clercq 《Journal of virological methods》1990,29(2):197-208
The inhibitory effects of a series of antiviral compounds on human immunodeficiency virus type 1 (HIV-1) were evaluated in a plaque assay (PA) in MT-4 cells and a focal immunoassay (FIA) in CD4+ HeLa cells. Similar 50% inhibitory concentrations (IC50) were obtained for the sulfated polysaccharides when measured by PA or FIA: the IC50 values of dextran sulfate and pentosan polysulfate were 0.8 microgram/ml and 0.35 microgram/ml, respectively. Also, comparable IC50 values (ranging from 1.42 to 2.71 microM) were obtained for purine 2',3'-dideoxyribosides (i.e. DDA, DDI and DDG) when evaluated by PA or FIA. In contrast, the IC50 values of pyrimidine 2',3'-dideoxyribosides were invariably 4- to 10-fold lower when monitored by PA than FIA: the IC50s of AZT, D4T and DDC in the PA were 0.015, 0.094 and 0.038 microM, respectively, and in the FIA were 0.062 microM, 0.29 microM and 0.46 microM, respectively. The differential anti-HIV-1 activities found with AZT, D4T and DDC in the PA and FIA systems may at least be related in part to differences in the metabolism of the compounds (i.e. phosphorylation by thymidine kinase or 2'-deoxycytidine kinase) between MT-4 and CD4+ HeLa cells. The novel anti-HIV-1 compounds tetrahydro-imidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione (TIBO) derivatives, R82150 and R82913, and the acyclouridine derivative 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) were also more inhibitory to HIV-1 in the PA than FIA system. The IC50 values of R82150, R82913 and HEPT, as based on PA, were 0.005, 0.003 and 0.79 microM, respectively. Their IC50 values, as based on FIA, were 0.020 microM, 0.015 microM and 3.77 microM, respectively. The TIBO derivatives emerged as the most effective HIV-1 inhibitors of the compounds tested whether assayed by PA or FIA. 相似文献
92.
High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b 总被引:8,自引:0,他引:8
K. Kanai M. Kako T. Kumada H. Tsubouchi T. Aikawa M. Kojima H. Harada T. Kawasaki M. Nakashima H. Okamoto S. Mishiro 《Archives of virology》1998,143(8):1545-1554
Summary. Efficacy of standard regimens (e.g., 3–6 MU for 24 weeks) of alfa-IFN therapy for chronic hepatitis C has been limited, particularly
in patients with HCV/1b. To see if higher-dose longer term treatment is more effective, we tried a 9 MU 60-week regimen. HCV/1b-infected
chronic hepatitis patients received 9 MU IFNα2a everyday but Sunday for 2 weeks and thrice a week for next 10 weeks, and 76
patients became HCV RNA-negative while 81 remained positive. The RNA-negative patients were then randomized to receive 3 MU
(group I, n=37) or 9 MU (group II, n=39) for 48 weeks. Of the RNA-positive patients, only those with normal ALT received another
9 MU 48-week treatment (group III, n=45). Sustained responders (SR) were defined as those with negative RNA and normal ALT
6 months after the therapy. SR rates based on intent-to-treat principle did not differ significantly between groups I and
II (30% vs 41%), but those based on the protocol-compatible cases showed a significant difference (32% vs 56%, p=0.034). SR
rate in group III was significantly lower than those in group II. Adverse effects of IFN, developed more frequently in groups
II and III than in group I, were mostly reversible. In conclusion, our results encourage 9 MU 60-week IFNα treatment in HCV/1b-infected
patients with careful attention to adverse effects, and suggest that the treatment should be discontinued if HCV RNA does
not disappear within 12 weeks.
Received February 18, 1998 Accepted March 19, 1998 相似文献
93.
Takeuchi K Aihara E Hayashi M Sasaki Y 《Medicinal chemistry (Shāriqah (United Arab Emirates))》2005,1(4):395-403
Gastroduodenal HCO3- secretion is a key process that aids in preventing acid-peptic injury. Endogenous prostaglandins (PGs) play a particularly important role in the local control of this secretion. The secretion of HCO3- in both the stomach and duodenum was increased in response to PGE2 as well as mucosal acidification, the latter occurring with concomitant enhancement of mucosal PG generation. These HCO3- responses in the duodenum were markedly reduced by prior administration of the EP4 antagonist in rats, and profoundly decreased in the animals lacking EP3 receptors but not EP1 receptors. In contrast, gastric HCO3- responses induced by PGE2 and mucosal acidification were prevented by the EP1 antagonist and disappeared in EP1, but not EP3-knockout mice. Consistent with these findings, duodenal HCO3- secretion was stimulated by both EP3 and EP4 agonists but not EP1 or EP2 agonists, while gastric HCO3- secretion was increased by the EP1 agonist but not EP2, EP3 or EP4 agonists. In addition, the HCO3- stimulatory action of sulprostone (EP1/EP3 agonist) in the stomach was inhibited by the Ca2+ antagonist verapamil but not affected by IBMX, the inhibitor of phosphodiesterase, while that in the duodenum was inhibited by verapamil and enhanced by IBMX. Forskolin, the stimulator of adenylate cyclase, increased HCO3- secretion in the duodenum but not the stomach. Thus, the HCO3- stimulatory action of PGE2 in the duodenum is mediated by both EP3 and EP4 receptors being coupled intracellularly with both Ca2+ and cAMP, while that in the stomach is mediated by EP1 receptors, coupled with Ca2+. 相似文献
94.
95.
J Hayashi M Hirata K Nakashima A Noguchi S Kashiwagi M Matsui H Ishibashi Y Maeda 《Fukuoka igaku zasshi》1991,82(12):648-654
508 Japanese patients with chronic liver disease, including chronic hepatitis, cirrhosis and hepatocellular carcinoma, and 500 controls matched for sex and age were studied. Antibody to hepatitis C virus (anti-HCV) alone was found in 233 (45.9%) patients and hepatitis B surface antigen (HBsAg) alone was present in 128 (25.2%) patients. Both anti-HCV and HBsAg were present in 18 (3.5%) patients. Anti-HCV was found in 8 (1.6%) controls and HBsAg was present in 4 (0.8%) controls. The prevalence of anti-HCV alone was 36.9% in chronic hepatitis, 49.0% in cirrhosis and 67.0% in hepatocellular carcinoma, respectively. The prevalence of anti-HCV increased with the progress of severity of liver disease. Anti-HCV was more prevalent than HBsAg both in cirrhosis and hepatocellular carcinoma (p less than 0.001). The prevalence of anti-HCV increased with age. Among patients under age 39 years, HBsAg was detected more often than anti-HCV, however, in those over age 50 years, anti-HCV was detected more often than HBsAg (p less than 0.001). It would appear that hepatitis C virus more than hepatitis B virus is a prominent cause of chronic liver disease among Japanese patients. 相似文献
96.
Nakashima T Sumida Y Yoh T Kakisaka Y Nakajima Y Ishikawa H Mitsuyoshi H Kashima K Nakamura H Yodoi J 《Antioxidants & redox signaling》2000,2(4):687-694
Thioredoxin (TRX), a thiol-containing protein, is induced by various oxidative stresses. Serum TRX levels were measured with a sandwich enzyme-linked immunosorbent assay kit in 210 hepatitis C virus (HCV)-infected patients, 39 hepatitis B virus (HBV)-infected patients, and 17 healthy volunteers. The effects of hepatoprotective drugs on TRX levels were also examined. The median TRX levels were significantly higher in HCV-infected patients than in controls (34.2 vs. 23.5 ng/ml, respectively; p < 0.005), but were not elevated in HBV-infected patients (26.7 ng/ml). The TRX levels were significantly correlated with serum lipid peroxide levels and indocyanine green exclusion test values, and were markedly decreased following treatment with Stronger Neo-Minophagen C or ursodeoxycholic acid. In conclusion serum TRX levels, a marker of oxidative stress, were higher in patients with HCV infection than those with HBV infection and healthy controls. The therapeutic efficacy of hepatoprotective drugs may be connected with the decrease in oxidative stress in hepatitis patients. 相似文献
97.
Epithelioid granulomas associated with hepatocellular carcinoma 总被引:1,自引:0,他引:1
98.
Histamine synthesis by non-mast cells through mitogen-dependent induction of histidine decarboxylase. 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Culture of spleen cells of C57BL/6 mice led to a spontaneous increase in activity of histidine decarboxylase (HDC) in the cell and the medium. Concomitantly histamine increased in the cells and, especially, in the medium. Addition of concanavalin A (Con A) or lipopolysaccharide (LPS) to the culture enhanced these processes. There was also a significant Con A-dependent increase in HDC activity and histamine biosynthesis in the culture of spleen cells of genetically mast-cell deficient W/Wv mice. Peritoneal macrophages of C57BL/6J mice had constitutively 11-19-fold as much HDC as T and B lymphocytes when compared on the basis of same number of cells. Con A had no effect on HDC activity when the macrophages were cultured alone. However, co-culture with T lymphocytes, separated from macrophages by a millipore filter membrane (pore size, 0.45 micron), rendered the macrophages responsive to Con A, leading to a notable increase in HDC activity in the cell. Addition of LPS caused a small but significant increase in HDC activity in macrophages, even when the cells were cultured alone. Co-culture with T or B cells enhanced the LPS-dependent increase in HDC activity in macrophages. In contrast, the HDC activity in T and B lymphocytes did not change essentially in the presence of any of these mitogens, even when they were co-cultured with macrophages. These results suggest that histamine is synthesized by non-mast cells through HDC. 相似文献
99.
Nakashima Y Tagawa H Suzuki R Karnan S Karube K Ohshima K Muta K Nawata H Morishima Y Nakamura S Seto M 《Genes, chromosomes & cancer》2005,44(3):247-255
Natural killer (NK) cell lymphomas/leukemias are highly aggressive lymphoid malignancies, but little is known about their genomic alterations, and thus there is an urgent need for identification and analysis of NK cell lymphomas/leukemias. Recently, we developed our own array-based comparative genomic hybridization (array CGH) with an average resolution of 1.3 Mb. We performed an array CGH analysis for 27 NK-cell lymphoma/leukemia cases that were classified into two disease groups based on the World Health Organization Classification (10 aggressive NK-cell leukemia cases and 17 extranodal NK/T-cell [NK/T] lymphomas, nasal type). We identified the differences in the genomic alteration patterns of the two groups. The recurrent regions characteristic of the aggressive NK-cell leukemia group compared with those of the extranodal NK/T lymphoma, nasal-type group, were gain of 1q and loss of 7p15.1-p22.3 and 17p13.1. In particular, gain of 1q23.1-24.2 (P = 0.041) and 1q31.3-q44 (P = 0.003-0.047), and loss of 7p15.1-p22.3 (P = 0.012-0.041) and 17p13.1 (P = 0.012) occurred significantly more frequently in the former than in the latter group. Recurrent regions characteristic of the extranodal NK/T lymphoma, nasal-type group, compared with those of the other group were gain of 2q, and loss of 6q16.1-q27, 11q22.3-q23.3, 5p14.1-p14.3, 5q34-q35.3, 1p36.23-p36.33, 2p16.1-p16.3, 4q12, and 4q31.3-q32.1. Our results can be expected to provide further insights into the genetic basis of lymphomagenesis and the clinicopathologic features of NK-cell lymphomas/leukemias. 相似文献
100.